(Q48190162)

9 February 2018

title

Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. (English)

1 reference

9 February 2018

0 references

1 reference

5

1 reference

9 February 2018

Zbigniew K Wszolek

2

object named as

Wszolek ZK

1 reference

9 February 2018

author name string

Tsuboi Y

1

1 reference

9 February 2018

Graff-Radford NR

3

1 reference

9 February 2018

Cookson N

4

1 reference

9 February 2018

publication date

1 October 2003

1 reference

9 February 2018

Neuropathology and Applied Neurobiology

published in

1 reference

9 February 2018

volume

29

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

503-510

1 reference

9 February 2018

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Presence of both odor identification and detection deficits in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Olfactory disorder in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Olfactory thresholds are associated with degree of dementia in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

The nature and course of olfactory deficits in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00453.X

10.1046/J.1365-2990.2003.00453.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018